Thursday
SESSION VI: UPDATE ON EVAR FOR AAAS: TRIALS, SURVEILLANCE AND MANAGEMENT OF COMPLICATIONS (7-MINUTE TALKS)
SESSION VI SCHEDULE
1:08 PM - 1:15 AM Mid-Term (Up To 3-Year) Results Of The Randomized Prospective DREAM Trial Comparing EVAR With Open AAA Repair: What Are The Implications?
  Presenters(s): Jan D. Blankensteijn, M.D.  
  View Abstract
1:16 PM - 1:23 PM Do Results Of The EVAR Trials (I and II) Justify Endovascular Repair Of All AAAs In Patients With Suitable Anatomy?
  Presenters(s): Roger M. Greenhalgh, MD  
  View Abstract
1:24 PM - 1:31 PM Don’t Assume AAA Growth After An Excluder Endograft Is Due To Permeability: AAA Enlargement In This Setting Is Multifactorial
  Presenters(s): Mark F. Fillinger, M.D.  
  View Abstract
1:32 PM - 1:39 PM AAA Sac Wall Compliance: How To Measure It And Does It Predict Rupture Potential - Correlation With Finite Element Analysis
  Presenters(s): Mohan Adiseshiah, F.R.C.S.  
  View Abstract
1:40 PM - 1:47 PM Dynamic CTA Can Assess Aneurysmal Wall Pulsatile Movement And Provide Information About Differences In Stent-Graft Performance And Effectiveness Of AAA Exclusion
  Presenters(s): Frans L. Moll, M.D., Ph.D.  
  View Abstract
1:48 PM - 1:55 PM Volume Changes And Sac Pressure Correlations In Patients After EVAR
  Presenters(s): Jan S. Brunkwall, M.D., Ph.D.  
  View Abstract
1:56 PM - 2:03 PM Proximal Attachment Failure Of AneuRx Endografts: How Can It Be Managed?
  Presenters(s): Mark A. Farber, M.D.  
  View Abstract
2:04 PM - 2:15 PM Panel Discussion
END OF SESSION VI